Other studies conducted in high income/low endemic settings aiming to differentiate active TB from latent TB infection (LTBI) irrespective of HIV status, and for evaluating TB treatment (18–21) led to the identification of interferon-gamma inducible protein (IP)-10 as a candidate biomarker for TB diagnosis. This evidence concerns the gene CXCL10 and tuberculosis.